0.028 † Used as the reference category. "Hyperenhancement" means that the tumor is equal or brighter than pancreatic parenchyma in the hepatic venous phase. Worrisome findings for the invasion of major vessels were based on the National Comprehensive Cancer Network criteria. Regional LN larger than 8mm, retroperitoneal LN larger than 10mm, or any LN with round-shape or necrosis was considered abnormal. Chronic pancreatitis was presumed if the underlying pancreas showed at least two of the following features -pancreatic parenchymal calcification, pancreaticolith, irregular dilatation of MPD, and diffuse pancreatic atrophy. HR, hazard ratio; CI, confidence interval; BMI, body mass index; PNI, prognostic nutritional index; CA 19-9, carbohydrate antigen 19-9; PPPD, pylorus-preserving pancreaticoduodenectomy; LN, lymph node; PNI, perineural invasion; LVI, lymphovascular invasion; CBD, common bile duct; AJCC, American Joint Committee on Cancer; CT, computed tomography; CA, celiac artery; SMA, superior mesenteric artery; GDA, gastroduodenal artery; PV, portal vein; SMV, superior mesenteric vein; MPD, main pancreatic duct. 
